These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17026491)

  • 1. Weight gain and insulin requirement in type 2 diabetic patients during the first year after initiating insulin therapy dependent on baseline BMI.
    Biesenbach G; Raml A; Alsaraji N
    Diabetes Obes Metab; 2006 Nov; 8(6):669-73. PubMed ID: 17026491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of glycaemic control and weight change in patients initiated with human or analog insulin in an US ambulatory care setting.
    McAdam-Marx C; Bouchard J; Aagren M; Nelson R; Brixner D
    Diabetes Obes Metab; 2010 Jan; 12(1):54-64. PubMed ID: 19758356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial.
    Yki-Järvinen H; Ryysy L; Nikkilä K; Tulokas T; Vanamo R; Heikkilä M
    Ann Intern Med; 1999 Mar; 130(5):389-96. PubMed ID: 10068412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight gain in insulin-treated patients by body mass index category at treatment initiation: new evidence from real-world data in patients with type 2 diabetes.
    Paul SK; Shaw JE; Montvida O; Klein K
    Diabetes Obes Metab; 2016 Dec; 18(12):1244-1252. PubMed ID: 27502528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.
    Kooy A; de Jager J; Lehert P; Bets D; Wulffelé MG; Donker AJ; Stehouwer CD
    Arch Intern Med; 2009 Mar; 169(6):616-25. PubMed ID: 19307526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia.
    Fonseca V; Gill J; Zhou R; Leahy J
    Diabetes Obes Metab; 2011 Sep; 13(9):814-22. PubMed ID: 21481127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus.
    Kothny W; Foley J; Kozlovski P; Shao Q; Gallwitz B; Lukashevich V
    Diabetes Obes Metab; 2013 Mar; 15(3):252-7. PubMed ID: 23039321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus.
    Mäkimattila S; Nikkilä K; Yki-Järvinen H
    Diabetologia; 1999 Apr; 42(4):406-12. PubMed ID: 10230643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.
    Lingvay I; Pérez Manghi F; García-Hernández P; Norwood P; Lehmann L; Tarp-Johansen MJ; Buse JB;
    JAMA; 2016 Mar; 315(9):898-907. PubMed ID: 26934259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pretreatment with low-dose metformin on metabolic parameters and weight gain by pioglitazone in Japanese patients with type 2 diabetes.
    Kawai T; Funae O; Shimada A; Tabata M; Hirata T; Atsumi Y; Itoh H
    Intern Med; 2008; 47(13):1181-8. PubMed ID: 18591838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial.
    Hollander P; Raslova K; Skjøth TV; Råstam J; Liutkus JF
    Diabetes Obes Metab; 2011 Mar; 13(3):268-75. PubMed ID: 21205123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
    Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of initiation of therapy with once-daily combination of a thiazolidinedione and a biguanide at an early stage of type 2 diabetes.
    Bell DS; Ovalle F
    Diabetes Obes Metab; 2004 Sep; 6(5):363-6. PubMed ID: 15287929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes.
    Vilsbøll T; Rosenstock J; Yki-Järvinen H; Cefalu WT; Chen Y; Luo E; Musser B; Andryuk PJ; Ling Y; Kaufman KD; Amatruda JM; Engel SS; Katz L
    Diabetes Obes Metab; 2010 Feb; 12(2):167-77. PubMed ID: 20092585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of glycemic control after a 3-5 day insulin infusion in type 2-diabetic patients with insulin resistance can be maintained with glitazone therapy.
    Biesenbach G; Grafinger P; Raml A
    Wien Klin Wochenschr; 2006 Sep; 118(17-18):543-8. PubMed ID: 17009067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial beta-cell protection in individuals with type 2 diabetes.
    Forst T; Larbig M; Hohberg C; Forst S; Diessel S; Borchert M; Roth W; Pfützner A
    Diabetes Obes Metab; 2010 May; 12(5):437-41. PubMed ID: 20415692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials.
    Lankisch MR; Del Prato S; Dain MP; Mullins P; Owens DR
    Prim Care Diabetes; 2016 Feb; 10(1):51-9. PubMed ID: 26150328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of basal insulin therapy in type 2 diabetes mellitus patients with or without metformin observed in a national cohort in China.
    Zhang P; Chen M; Zhang H; Luo Y; Zhu D; Li X; Ji J; Wang D; Duolikun N; Ji L
    BMC Endocr Disord; 2022 Jan; 22(1):26. PubMed ID: 35045841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.